Patents by Inventor Karoline Schjetne

Karoline Schjetne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240173391
    Abstract: This invention relates to methods and kits for treating a subject having cancer, e.g. a patient, by administering to the subject an anticancer vaccine in combination with one or more checkpoint inhibitors.
    Type: Application
    Filed: March 25, 2022
    Publication date: May 30, 2024
    Applicant: Nykode Therapeutics ASA
    Inventors: Agnete Øvre Fredriksen, Karoline Schjetne, Stine Granum, Audun Trygge Haugen Bersaas, Ina Park Rhee, Siri Brinchmann-Hansen Torhaug
  • Publication number: 20230293650
    Abstract: The present invention relates to an individualized therapeutic anticancer vaccine, methods of treatment of cancer wherein such an anticancer vaccine is used as well as methods for producing the vaccine.
    Type: Application
    Filed: April 9, 2021
    Publication date: September 21, 2023
    Applicant: Nykode Therapeutics ASA
    Inventors: Agnete Brunsvik Fredriksen, Monika Sekelja, Karoline Schjetne, Stine Granum
  • Publication number: 20230165952
    Abstract: Disclosed is a vaccine comprising an immunologically effective amount of a polynucleotide comprising a nucleotide sequence encoding a targeting unit, a dimerization unit and an antigenic unit, wherein the antigenic unit comprises at least one betacoronavirus epitope. The vaccine is ideal for pandemic and epidemics as it can induce rapid, strong immune response with lower/fewer doses because the antigen is targeted to antigen presenting cells and the antigen is produced in the body.
    Type: Application
    Filed: May 3, 2021
    Publication date: June 1, 2023
    Applicant: Nykode Therapeutics ASA
    Inventors: Agnete Brunsvik Fredriksen, Monika Sekelja, Karoline Schjetne, Gunnstein Norheim, Elisabeth Stubsrud
  • Publication number: 20210388438
    Abstract: The present invention relates to a method for selecting neoepitopes for an individual, by selecting MHC I and/or MHC II binding neoepitopes and ranking them with respect the methods as described herein.
    Type: Application
    Filed: September 27, 2019
    Publication date: December 16, 2021
    Applicant: VACCIBODY AS
    Inventors: Monika Sekelja, Karoline Schjetne, Agnete Brunsvik Fredriksen
  • Publication number: 20200109197
    Abstract: Provided are methods and composition useful in isolating or otherwise preparing a population of target cells. In part, it relates to recombinant antibodies comprising an exogenous proteolytic cleavage site and nucleic acid molecules encoding the antibodies.
    Type: Application
    Filed: September 4, 2019
    Publication date: April 9, 2020
    Inventors: Karoline Schjetne, Tanja Aarvak, Lars Norderhaug
  • Publication number: 20170313772
    Abstract: Provided are methods and composition useful in isolating or otherwise preparing a population of target cells. In part, it relates to recombinant antibodies comprising an exogenous proteolytic cleavage site and nucleic acid molecules encoding the antibodies.
    Type: Application
    Filed: February 15, 2017
    Publication date: November 2, 2017
    Inventors: Karoline Schjetne, Tanja Aarvak, Lars Norderhaug
  • Publication number: 20150175698
    Abstract: Provided are methods and composition useful in isolating or otherwise preparing a population of target cells. In part, it relates to recombinant antibodies comprising an exogenous proteolytic cleavage site and nucleic acid molecules encoding the antibodies.
    Type: Application
    Filed: March 6, 2013
    Publication date: June 25, 2015
    Inventors: Karoline Schjetne, Tanja Aarvak, Lars Norderhaug
  • Patent number: D733914
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: July 7, 2015
    Assignee: Life Technologies AS
    Inventors: Axl Neurauter, Berit Reed, Karoline Schjetne, Jeremy (“Jez”) Mundy, Tine Hildisch